We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Enhanced Stent Retriever Treats Ischemic Stroke

By HospiMedica International staff writers
Posted on 30 May 2018
A next-generation stent retriever captures and removes life-threatening blood clots from the brain following an ischemic stroke.

The Cerenovus (Irvine, CA, USA) EmboTrap II revascularization device is intended to restore blood flow in the neurovasculature by removing thrombii in patients experiencing ischemic stroke within eight hours of symptom onset. More...
The 0.021”, microcatheter compatible clot retriever is designed to trap blood clots with minimum compression, rapidly deliver thrombolysis in cerebral infarction (TICI) 2b-3 reperfusion therapy, and retain the clots during removal to protect the patient from distal embolisms.

The EmboTrap II, which is available in both 5×33 and 5×21 sizes, features an inner channel that allows bypass while open, and five chambers to improve the clot-device interaction. The device also has a distal section with an extensive mesh designed to keep the clot in place, so that it does not fragment. The analysis of revascularisation in ischemic stroke with EmboTrap (ARISE II) study showed a final procedural reperfusion rate of 92.5% among acute ischemic stroke patients with large vessel occlusion within three passes of the EmboTrap II.

“Embotrap II is the product of deep collaboration between engineers and clinicians to better understand the science of blood clot, what causes them to form and how a mechanical thrombectomy device can interact with them to help improve outcomes,” said Daniella Cramp, worldwide president of Cerenovus. “Cerenovus is committed to advancing treatment with evidence-based solutions so that fewer and fewer people are affected by the ravages of stroke.”

“The EmboTrap platform has been a great addition to my clinical practice. In my first nine cases using the device, I was able to get TICI 2b-3 reperfusion in one pass. Now, with the EmboTrap II, I’ve had comparably good results when treating longer occlusions,” said professor of radiology Christian Taschner, MD, of the University of Freiburg (Germany). “The open design of the device helps trap clot inside and also makes it quite flexible, which is important when removing clot from the arteries of the brain.”

Stent retrievers are deployed in an occluded vessel and are temporarily expanded into the body of a thrombus in order to recanalize the vessel, allowing for reperfusion of ischemic sites and causing the thrombus to be partially entangled within the stent. Thrombectomy is then performed by retracting the stent.

Related Links:
Cerenovus


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.